Christine Årdal

2.0k citations
46 papers · 988 indexed · 1 hit paper · h-index 15
Topics
Pharmaceutical Economics and Policy (25 papers)Antibiotic Use and Resistance (24 papers)Antibiotic Resistance in Bacteria (7 papers)
Journals
The LancetNature CommunicationsSHILAP Revista de lepidopterología

In The Last Decade

Christine Årdal

41 papers receiving 949 citations

Hit Papers

Antibiotic development — economic, regulatory and societa...2019202620212023201950100150200250

Peers

Christine Årdal
Comparison fields: 5 of 131
  • Applied Microbiology and Biotechnology 251
  • Economics and Econometrics 246
  • Molecular Medicine 192
  • Public Health, Environmental and Occupational Health 175
  • Molecular Biology 166
Replace Anthony D. So with:
Anthony D. So United States
Aidan Hollis Canada
Chantal Morel United Kingdom
Prince Sultan Military Medical City
Laurence Roope United Kingdom
Nithima Sumpradit Thailand
Robert Townsend United States
Diana Weil Switzerland
Manica Balasegaram Switzerland
Lucy Abel United Kingdom
Christine Årdal relative to Anthony D. So United States Anthony D. So's profile →
Citations per field
00.5×2.8×
Anthony D. So · 1×
Citations per year

Countries citing papers authored by Christine Årdal

Since Specialization
Citations

This map shows the geographic impact of Christine Årdal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christine Årdal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christine Årdal more than expected).

Fields of papers citing papers by Christine Årdal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christine Årdal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christine Årdal. The network helps show where Christine Årdal may publish in the future.

Co-authorship network of co-authors of Christine Årdal

This figure shows the co-authorship network connecting the top 25 collaborators of Christine Årdal. A scholar is included among the top collaborators of Christine Årdal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christine Årdal. Christine Årdal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 0
4 1
5 0
6 0
7 3
8 2
9 10
10 2
11 14
12 10
13
Revitalizing the antibiotic pipeline: Stimulating innovation while driving sustainable use and global access
33
14 14
15 49
16 20
17 25
18 10
19 2
20 197

About Christine Årdal

Christine Årdal is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Business and International Management, having authored 46 papers that have together received 988 indexed citations. Recurring topics across this work include Pharmaceutical Economics and Policy (25 papers), Antibiotic Use and Resistance (24 papers) and Antibiotic Resistance in Bacteria (7 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (251 citations), Molecular Medicine (192 citations) and Microbiology (60 citations). Christine Årdal has collaborated with scholars based in Norway, United States and Sweden. Frequent co-authors include Kevin Outterson, John‐Arne Røttingen, John Rex, Ramanan Laxminarayan, Manica Balasegaram, Nithima Sumpradit, David McAdams, Stephen A. Matlin, Roderik F. Viergever and Robert Terry. Their work appears in journals such as The Lancet, Nature Communications and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026